The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
A re‐examination of the epstein‐barr virus carrier state in healthy seropositive individuals
Abstract
A panel of 24 healthy seropositive donors have been followed prospectively over a period of 15 months and monitored (1) for the level of EB virus shedding in the throat by means of a sensitive cord‐blood transformation assay; (2) for the level of virus‐infected B cells in the blood via a new in vitro protocol where “spontaneous transformation” can be seen to titrate against input cell number; (3) for anti‐EB viral antibody titres and (4) for the prevailing level of virus‐specific memory T cells in the circulation. Six donors shed easily detectable levels of EB virus into throat washings on every occasion of testing, whilst 16 other donors shed lower levels of virus detectable in throat washings on a majority (10 donors) or on a minority (6 donors) of test occasions; only 2/24 donors gave no evidence of virus shedding at any time. There was a direct relationship between the EB virus shedder status of an individual (i. e., the level of virus replication in the pharynx) and the number of infected B cells present in the circulation. These results indicate that chronic, usually low‐grade, replication of the virus at some permissive site in the oro‐and/or naso‐pharynx is very often a stable accompaniment of the asymptomatic EB virus carrier state, and may indeed be essential for the long‐term maintenance of that state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reedman, B. M., & Klein, G. (1973) · International Journal of Cancer · doi:10.1002/ijc.2910110302 · Cited by 1,668
Immunofluorescence in Cells Derived from Burkitt's Lymphoma
Henle, G., & Henle, W. (1966) · Journal of Bacteriology · doi:10.1128/jb.91.3.1248-1256.1966 · Cited by 1,439
Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells
Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., & Pagano, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405103101905 · Cited by 723
Henle, W., Diehl, V., Kohn, G., zur Hausen, H., & Henle, G. (1967) · Science · doi:10.1126/science.157.3792.1064 · Cited by 588
Pope, J. H., Horne, M. K., & Scott, W. M. (1968) · International Journal of Cancer · doi:10.1002/ijc.2910030619 · Cited by 472
Nilsson, K., Klein, G., Henle, W., & Henle, G. (1971) · International Journal of Cancer · doi:10.1002/ijc.2910080312 · Cited by 357
ORAL EXCRETION OF EPSTEIN-BARR VIRUS BY HEALTHY SUBJECTS AND PATIENTS WITH INFECTIOUS MONONUCLEOSIS
GERBER, P. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92402-6 · Cited by 267
Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell lines
Bird, A. G., McLachlan, S. M., & Britton, S. (1981) · Nature · doi:10.1038/289300a0 · Cited by 239
Long-term T-cell-mediated immunity to Epstein-Barr virus.
Rickinson, A. B., Moss, D. J., Wallace, L. E., Rowe, M., MISKO, I. S., Epstein, M. A., & Pope, J. H. (1981) · PubMed · Cited by 210
Self-citationEbels, T., & Homan Van Der Heide, J. N. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90264-1 · Cited by 188
Cited by
Cohen, J. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430707 · Cited by 1,636
Epstein-Barr virus: exploiting the immune system
Thorley-Lawson, D. A. (2001) · Nature Reviews Immunology · doi:10.1038/35095584 · Cited by 939
Caldwell, R. G., Wilson, J. B., Anderson, S. J., & Longnecker, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80623-8 · Cited by 597
Epstein–Barr virus and oncogenesis: from latent genes to tumours
Young, L. S., & Murray, P. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206556 · Cited by 556
Laichalk, L. L., & Thorley-Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1296-1307.2005 · Cited by 538
Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes
Sample, J., Young, L., Martin, B., Chatman, T., Kieff, E., Rickinson, A., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4084-4092.1990 · Cited by 497
Self-citationSPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
Kutok, J. L., & Wang, F. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100209 · Cited by 493
Tierney, R. J., Steven, N., Young, L. S., & Rickinson, A. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7374-7385.1994 · Cited by 482
Self-citationThe Pathogenesis of Burkitt's Lymphoma
(1990) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60470-4 · Cited by 466
Gillespie, G. M. A., Wills, M. R., Appay, V., O'Callaghan, C., Murphy, M., Smith, N., Sissons, P., Rowland-Jones, S., Bell, J. I., & Moss, P. A. H. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8140-8150.2000 · Cited by 420
Steven, N. M., Annels, N. E., Kumar, A., Leese, A. M., Kurilla, M. G., & Rickinson, A. B. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1605 · Cited by 350
Self-citationEpstein-Barr virus—recent advances
Macsween, K. F., & Crawford, D. H. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00543-7 · Cited by 344
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions
De Paschale, M. (2012) · World Journal of Virology · doi:10.5501/wjv.v1.i1.31 · Cited by 333
EBV Persistence—Introducing the Virus
Thorley-Lawson, D. A. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-22822-8_8 · Cited by 333
Gustafsson, A., Levitsky, V., Zou, J.-Z., Frisan, T., Dalianis, T., Ljungman, P., Ringden, O., Winiarski, J., Ernberg, I., & Masucci, M. G. (2000) · Blood · doi:10.1182/blood.v95.3.807.003k24_807_814 · Cited by 330
Human herpesviruses: a consideration of the latent state
Stevens, J. G. (1989) · Microbiological Reviews · doi:10.1128/mmbr.53.3.318-332.1989 · Cited by 312
Rowe, M., Young, L. S., Crocker, J., Stokes, H., Henderson, S., & Rickinson, A. B. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.147 · Cited by 301
Self-citationDETECTION OF A SECOND WIDESPREAD STRAIN OF EPSTEIN-BARR VIRUS
Sixbey, J., Chesney, P. J., Shirley, P., Buntin, D., & Resnick, L. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90829-5 · Cited by 290
Biology and disease associations of Epstein–Barr virus
Crawford, D. H. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2000.0783 · Cited by 285
The diagnosis and treatment of posttransplant lymphoproliferative disorders
Nalesnik, M. A., Makowka, L., & Starzl, T. E. (1988) · Current Problems in Surgery · doi:10.1016/0011-3840(88)90011-1 · Cited by 275
Munch, M., Møller-Larsen, A., Christensen, T., Morling, N., Hansen, H. J., & Haahr, S. (1995) · Multiple Sclerosis Journal · doi:10.1177/135245859500100204 · Cited by 45
Metadata
- Authors
- Yao, Q. Y., Rickinson, A. B., & Epstein, M. A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1985-01-15
- Volume
- 35
- Issue
- 1
- Pages
- 35-42
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2012161992
- Cited by
- 338
- References
- 11
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.